2864 Stock Overview
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥28.91 |
52 Week High | CN¥51.57 |
52 Week Low | CN¥22.00 |
Beta | -0.14 |
1 Month Change | -6.80% |
3 Month Change | -22.03% |
1 Year Change | -26.98% |
3 Year Change | 24.77% |
5 Year Change | -16.64% |
Change since IPO | 100.21% |
Recent News & Updates
Shareholder Returns
2864 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -9.9% | -3.4% | -2.2% |
1Y | -27.0% | -11.4% | -14.8% |
Return vs Industry: 002864 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 002864 underperformed the CN Market which returned -14.8% over the past year.
Price Volatility
2864 volatility | |
---|---|
2864 Average Weekly Movement | 8.1% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.4% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 002864's share price has been volatile over the past 3 months.
Volatility Over Time: 002864's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 935 | Xiaolin Xie | https://www.pljt.com |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Fundamentals Summary
2864 fundamental statistics | |
---|---|
Market cap | CN¥3.04b |
Earnings (TTM) | CN¥107.30m |
Revenue (TTM) | CN¥997.08m |
28.3x
P/E Ratio3.0x
P/S RatioIs 2864 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2864 income statement (TTM) | |
---|---|
Revenue | CN¥997.08m |
Cost of Revenue | CN¥417.30m |
Gross Profit | CN¥579.78m |
Other Expenses | CN¥472.48m |
Earnings | CN¥107.30m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 1.02 |
Gross Margin | 58.15% |
Net Profit Margin | 10.76% |
Debt/Equity Ratio | 6.6% |
How did 2864 perform over the long term?
See historical performance and comparison